Imatinib Mesylate in Treating Patients With Recurrent Brain Tumor
Status: | Active, not recruiting |
---|---|
Conditions: | Brain Cancer |
Therapuetic Areas: | Oncology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 1/26/2019 |
Start Date: | June 2003 |
Phase I/II Trial of Imatinib Mesylate; (Gleevec; STI571) in Treatment of Recurrent Oligodendroglioma and Mixed Oligoastrocytoma
This phase I/II trial is studying the side effects and best dose of imatinib mesylate and to
see how well it works in treating patients with a recurrent brain tumor that has not
responded to previous surgery and radiation therapy. Imatinib mesylate may stop the growth of
tumor cells by blocking the enzymes necessary for tumor cell growth.
see how well it works in treating patients with a recurrent brain tumor that has not
responded to previous surgery and radiation therapy. Imatinib mesylate may stop the growth of
tumor cells by blocking the enzymes necessary for tumor cell growth.
PRIMARY OBJECTIVES:
I. To identify the maximum tolerated dose of imatinib (imatinib mesylate) in patients with
recurrent oligodendroglioma and mixed oligoastrocytoma that are currently on enzyme inducing
anticonvulsant therapy. (Study 1) II. To assess the efficacy of imatinib in patients with
recurrent oligodendrogliomas and mixed oligoastrocytomas (with pathologic evidence of
oligodendrogliomatous component) as measured by progression-free survival, response, and
overall survival. (Study 2) III. To acquire pilot data on a patient group not traditionally
eligible for recurrent oligodendroglioma and mixed oligoastrocytoma clinical trials (those
having > 2 prior chemotherapy regimens or 2 prior chemotherapy regimens for
recurrent/progressive disease). (Study 3) IV. To examine the toxicity and safety of imatinib
in patients with recurrent oligodendrogliomas and mixed oligoastrocytomas (with pathologic
evidence of oligodendrogliomatous component). (Studies 1, 2, and 3) V. To perform a
preliminary correlative study of 1p/19q alterations, alpha platelet-derived growth factor
receptor (PDFGR) gene amplification and levels of related downstream signaling elements in
tumor tissue, with clinical study endpoints. (Studies 1, 2, and 3) VI. To perform a
descriptive correlative analysis of steady state pharmacokinetic data regarding imatinib and
active metabolites with the study endpoints. (Studies 1, 2, and 3)
OUTLINE: This is a phase I, dose-escalation study followed by a phase II and a pilot study.
I. To identify the maximum tolerated dose of imatinib (imatinib mesylate) in patients with
recurrent oligodendroglioma and mixed oligoastrocytoma that are currently on enzyme inducing
anticonvulsant therapy. (Study 1) II. To assess the efficacy of imatinib in patients with
recurrent oligodendrogliomas and mixed oligoastrocytomas (with pathologic evidence of
oligodendrogliomatous component) as measured by progression-free survival, response, and
overall survival. (Study 2) III. To acquire pilot data on a patient group not traditionally
eligible for recurrent oligodendroglioma and mixed oligoastrocytoma clinical trials (those
having > 2 prior chemotherapy regimens or 2 prior chemotherapy regimens for
recurrent/progressive disease). (Study 3) IV. To examine the toxicity and safety of imatinib
in patients with recurrent oligodendrogliomas and mixed oligoastrocytomas (with pathologic
evidence of oligodendrogliomatous component). (Studies 1, 2, and 3) V. To perform a
preliminary correlative study of 1p/19q alterations, alpha platelet-derived growth factor
receptor (PDFGR) gene amplification and levels of related downstream signaling elements in
tumor tissue, with clinical study endpoints. (Studies 1, 2, and 3) VI. To perform a
descriptive correlative analysis of steady state pharmacokinetic data regarding imatinib and
active metabolites with the study endpoints. (Studies 1, 2, and 3)
OUTLINE: This is a phase I, dose-escalation study followed by a phase II and a pilot study.
Inclusion Criteria:
- Study 1 Arm C:
- Currently on anticonvulsants which can induce cytochrome p450 (phenytoin,
carbamazepine, barbiturates, primidone and if unsure contact study chair)
- =< 2 prior chemotherapy regimens (with maximum of 1 prior chemotherapy regimen
for recurrent disease)
- Study 2 Arms A and B:
- On or off anticonvulsants
- =< 2 prior chemotherapy regimens (with maximum of 1 prior chemotherapy regimen
for recurrent disease)
- Study 3 Arms D and E:
- On or off anticonvulsants
- > 2 chemotherapy regimens or 2 prior chemotherapy regimens for
progressive/recurrent disease
- All Arms:
- Histological confirmation of a grade 2-4 oligodendroglioma, or mixed oligoastrocytoma
grade 2-4 containing oligodendrogliomatous component on central pathology review prior
to study registration, and a diagnosis of recurrence; tissues from all available prior
surgeries should be sent, in particular those from time of initial diagnosis
- Measurable or evaluable disease by magnetic resonance imaging (MRI) or computed
tomography (CT) scan
- Fixed dose of corticosteroids (or no corticosteroids) for at least 1 week prior to the
pre-study baseline scan
- Patients undergoing surgery for initial or progressive disease, must be at least 2
weeks from the date of surgery, must have recovered from the effects of their surgery,
and must have unequivocal tumor growth on the pre-study baseline neuroimaging study as
compared to the first post-operative scan, unless there is a separate lesion or
residual disease compatible with tumor that is not within the surgical bed
- Unequivocal evidence of tumor progression by MRI or CT scan performed =< 21days prior
to study registration
- Must have failed surgery/radiotherapy (RT) and Temozolomide or nitrosourea based
therapy
- >= 12 weeks since the completion of RT
- Absolute neutrophil count (ANC) >= 1500/mm^3
- Platelets (PLT) >= 100,000/mm^3
- Hemoglobin (Hgb) >= 9 g/dL
- Total bilirubin =< 1.5 mg/dL
- Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) =< 3
x upper limit of normal (ULN)
- Creatinine =< 2.0 mg/dL
- Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0, 1, or 2
- >= 6 weeks since the last day of nitrosourea-based chemotherapy prior to study entry
- >= 4 weeks from any investigational agents prior to study entry
- >= 4 weeks from other chemotherapy prior to study entry
- >= 2 weeks from vincristine and biologic non-cytotoxic agents, e.g., tamoxifen,
thalidomide, cis-retinoic acid, interferon, etc, prior to study entry
- Patients or designated individual(s) with durable medical power of attorney for the
patient must be able to provide informed, written consent, and complete any required
study questionnaire(s) within the specifications of this study
Exclusion Criteria:
- All Arms
- Receiving warfarin or heparin
- Received prior stereotactic radiosurgery, interstitial brachytherapy, or interstitial
chemotherapy including carmustine (BCNU) wafers unless there is a separate lesion on
MRI, which is not part of the previous treatment field
- Active uncontrolled infection
- History of myocardial infarction =< 6 months or congestive heart failure (CHF)
requiring use of ongoing maintenance therapy for life-threatening ventricular
arrhythmias; patients must have a New York Heart Association (NYHA) of class II or
less; (NYHA class I: patients with no limitation of activities; they suffer no
symptoms from ordinary activities; class II: patients with slight, mild limitation of
activity; they are comfortable with rest or with mild exertion; class III: patients
with marked limitation of activity; they are comfortable only at rest; class IV:
patients who should be at complete rest, confined to bed or chair; any physical
activity brings on discomfort and symptoms occur at rest)
- Other severe concurrent disease which, in the judgment of the investigator, would make
the patient inappropriate for entry into this study or interfere significantly with
the interpretation of potential drug-induced toxicities
- Women of child-bearing potential, pregnant or nursing; such patients must have a
negative pregnancy test (b-HCG) =< 7 days prior to study registration
- Men or women of childbearing potential, not willing to employ adequate contraception
(condoms, diaphragm, birth control pills, injections, intrauterine device [IUD],
surgical sterilization, subcutaneous implants, or abstinence, etc.); the efficacy of
oral contraceptives may be decreased in patients who receive p450-inducing
anticonvulsants; for these patients, use of a second mode of contraception is
recommended; patients of childbearing potential must utilize effective contraception
and avoid becoming pregnant or fathering a child for 6 months after completing study
drug
- Other active malignancy, besides skin carcinomas (must not be melanoma)
- Concomitant serious immunocompromised status (other than that related to concomitant
steroids); patients that are human immunodeficiency virus (HIV) positive are eligible,
provided that there is no other reason for exclusion, based on the eligibility as
outlined elsewhere in this section
- Significant intratumoral hemorrhage on baseline MRI or CT, or other history of
significant intratumoral hemorrhage
We found this trial at
228
sites
Toledo Clinic Cancer Centers-Oregon Our doctors evaluate and make recommendations regarding cancer treatment for newly...
Click here to add this to my saved trials
1300 Jefferson Park Avenue
Charlottesville, Virginia 22908
Charlottesville, Virginia 22908
434-243-6784
University of Virginia Cancer Center We are fortunate in having state of the art clinical...
Click here to add this to my saved trials
Hurley Medical Center From its founding in 1908, Hurley Medical Center has devoted itself to...
Click here to add this to my saved trials
Mount Sinai Med Ctr Founded in 1852, The Mount Sinai Hospital is a 1,171-bed, tertiary-care...
Click here to add this to my saved trials
Avera Cancer Institute Avera, the health ministry of the Benedictine and Presentation Sisters, is a...
Click here to add this to my saved trials
Click here to add this to my saved trials
Bixby Medical Center ProMedica's Mission is to improve your health and well-being. Which is why,...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
McFarland Clinic PC-William R Bliss Cancer Center The William R. Bliss Cancer Center at Mary...
Click here to add this to my saved trials
Click here to add this to my saved trials
Saint Joseph Mercy Hospital St. Joseph Mercy Ann Arbor Hospital is a 537-bed teaching hospital...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Rush - Copley Medical Center Rush-Copley is proud to be the leading provider of health...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Saint Vincent Healthcare The Sisters of Charity of Leavenworth, Kansas, founded St. Vincent Healthcare in...
Click here to add this to my saved trials
Mid Dakota Clinic, PC We're your family clinic, with the doctors you know and trust...
Click here to add this to my saved trials
Saint Alexius Medical Center St. Alexius Medical Center is a 306-bed, full-service, acute care medical...
Click here to add this to my saved trials
Sanford Bismarck Medical Center Whether your stay in our hospital is one day for same...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Toledo Clinic Cancer Centers-Bowling Green Our doctors evaluate and make recommendations regarding cancer treatment for...
Click here to add this to my saved trials
Bozeman Deaconess Cancer Center Bozeman Deaconess Cancer Center provides the latest cancer technologies and treatment...
Click here to add this to my saved trials
Click here to add this to my saved trials
Bozeman Deaconess Hospital Bozeman Deaconess Hospital is a Joint Commission certified, licensed Level III trauma...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Fairview Ridges Hospital Fairview Ridges Hospital is a 150-bed, Level III Trauma Care facility, offering...
Click here to add this to my saved trials
Click here to add this to my saved trials
400 South Clark Street
Butte, Montana 59701
Butte, Montana 59701
406-723-2500
Saint James Community Hospital and Cancer Treatment Center St. James Healthcare has played an important...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Memorial Hospital Memorial Hospital is a vital force in establishing and maintaining the well-being of...
Click here to add this to my saved trials
Rocky Mountain Oncology Rocky Mountain Oncology Center is a spacious, comfortable, state-of-the-art 19,000 square foot...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Cancer Center of Kansas, PA - Chanute Dr. H.E. Hynes founded Cancer Center of Kansas,...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Mercy Hospital Mercy Hospital, located in Coon Rapids, Minnesota, is a 271-bed non-profit hospital that...
Click here to add this to my saved trials
Click here to add this to my saved trials
Geisinger Medical Center Since 1915, Geisinger Medical Center has been known as the region’s resource...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Mercy Medical Center - Des Moines Mercy Medical Center
Click here to add this to my saved trials
Iowa Methodist Medical Center Iowa Methodist Medical Center was established in 1901 in a single...
Click here to add this to my saved trials
3800 Park Nicollet Blvd
Des Moines, Iowa 50309
Des Moines, Iowa 50309
(952) 993-1516
Iowa Oncology Research Association CCOP The Iowa Oncology Research Association (IORA) was established by a...
Click here to add this to my saved trials
Iowa Lutheran Hospital Iowa Lutheran Hospital has a long history of serving the Des Moines...
Click here to add this to my saved trials
Saint John Hospital and Medical Center Founded in 1952, St. John Hospital and Medical Center...
Click here to add this to my saved trials
Cancer Center of Kansas, PA - Dodge City Dr. H.E. Hynes founded Cancer Center of...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Fairview Southdale Hospital Fairview Health Services is an award-winning nonprofit health care system based in...
Click here to add this to my saved trials
Cancer Center of Kansas, PA - El Dorado Dr. H.E. Hynes founded Cancer Center of...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Blanchard Valley Hospital For more than 100 years, Blanchard Valley Hospital has made quality care...
Click here to add this to my saved trials
420 S Saginaw St
Flint, Michigan 48502
Flint, Michigan 48502
810-232-3522
Genesys Regional Medical Center-West Flint Campus The health care team at Genesys Downtown Flint Health...
Click here to add this to my saved trials
Cancer Center of Kansas - Fort Scott Dr. H.E. Hynes founded Cancer Center of Kansas,...
Click here to add this to my saved trials
Fredericksburg Oncology Inc Fredericksburg Oncology is dedicated to offering each patient individual care and attention...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Unity Hospital Unity Hospital is one of the Twin Cities
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Illinois CancerCare - Galesburg Illinois CancerCare, P.C. is a comprehensive practice treating patients withcancer andblood...
Click here to add this to my saved trials
Click here to add this to my saved trials
1117 29th St S
Great Falls, Montana 59405
Great Falls, Montana 59405
(406) 771-7300
Benefis Healthcare- Sletten Cancer Institute Benefis Hospitals has 516 beds at its two campuses (that...
Click here to add this to my saved trials
Great Falls Clinic Founded in 1917, the Great Falls Clinic is the fourth oldest medical...
Click here to add this to my saved trials
114 Woodland St
Hartford, Connecticut 06105
Hartford, Connecticut 06105
(860) 714-4000
Saint Francis Hospital and Medical Center Saint Francis Hospital and Medical Center has come a...
Click here to add this to my saved trials
Mason District Hospital Mason District Hospital is dedicated to providing superior healthcare close to home...
Click here to add this to my saved trials
Northern Montana Hospital Northern Montana Hospital (NMH) is the center of a comprehensive system of...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Hutchinson Area Health Care Hutchinson Health is a team of medical professionals and support staff...
Click here to add this to my saved trials
Cancer Center of Kansas-Independence Dr. H.E. Hynes founded Cancer Center of Kansas, P. A. in...
Click here to add this to my saved trials
Click here to add this to my saved trials
Allegiance Health Allegiance Health is a community-owned and locally-governed health system in Jackson, Michigan. We...
Click here to add this to my saved trials
Mayo Clinic Florida Thousands of people come to Mayo Clinic in Jacksonville, Fla., annually for...
Click here to add this to my saved trials
Click here to add this to my saved trials
Glacier Oncology, PLLC Glacier Oncology are physician clinics focusing exclusively on the medical subspecialties of...
Click here to add this to my saved trials
Kalispell Regional Medical Center Nestled in the beautiful Flathead Valley of Northwestern Montana, Kalispell Regional...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials